Editor's Note: the "Trending USA Stocks" column tracks the day's top bullish stocks in the USA market, aiding investors in promptly identifying opportunities for potential gains.

14/05/2025 Eastern Time in USA, the Dow Jones Industrial Average dropped by 0.21%, closing at 42051.06 points; the Nasdaq Composite rose by 0.72%, closing at 19146.81 points; the S&P 500 Index rose by 0.1%, closing at 5892.58 points. 

Sahm has compiled the Top 10 Daily Stock Price Gainers in the USA market.

NWTN Inc Ordinary Shares - Class B: Overnight gain 76.5%, New CEO appointment and EV focus drive positive market sentiment

NWTN Inc., a smart electric vehicle (EV) company incorporated in the British Virgin Islands, primarily operates through its subsidiary ICONIQ Holding Limited. The firm is dedicated to integrating cutting-edge design, personalized lifestyle features, Internet of Things (IoT) connectivity, and autonomous driving technologies. The company's mission is to develop passenger-centric, global green premium mobility solutions, aiming to deliver innovative smart mobility experiences to its clientele. NWTN Inc. positions itself at the intersection of luxury automotive design and advanced technology, with a focus on creating sustainable transportation options for the high-end market. By leveraging its expertise in smart EV technology and premium vehicle manufacturing, NWTN Inc. seeks to capitalize on the growing demand for environmentally friendly luxury vehicles. The company's strategy aligns with global trends towards electrification and autonomous driving in the automotive sector, potentially positioning it to compete in the evolving landscape of premium electric mobility.

NWTN Inc Ordinary Shares - Class B(NWTN.US) experienced a significant surge in stock price, driven by multiple factors. The company's announcement of Benjamin Bin Zhai as the new CEO, replacing Alan Wu, was perceived positively by the market. As a smart electric vehicle company, NWTN's business aligns with the current trends in new energy and autonomous driving, attracting investor attention. The stock's year-to-date gain of 70.9% demonstrates sustained strong performance. The recent 76.5% spike in the latest trading session reflects optimistic market expectations for the company's future. These developments underscore NWTN's potential in the evolving automotive industry and its ability to capitalize on emerging market opportunities.

Newegg Commerce, Inc. - Common Shares: Overnight gain 53.6%, E-commerce giant benefits from tech demand surge, investor optimism drives stock rally

Newegg Commerce, Inc. (NASDAQ: NEGG), a leading global e-commerce company, was incorporated in the British Virgin Islands in 2003 and maintains its headquarters in the City of Industry, California. The company has established itself as a prominent player in the e-commerce sector, specializing in direct sales and online marketplace platforms for IT components, consumer electronics, entertainment products, smart home devices, and gaming merchandise. In addition to its core retail operations, Newegg Commerce, Inc. has diversified its offerings to include third-party logistics services and global fulfillment solutions. This strategic expansion has allowed the company to leverage its expertise in supply chain management and further solidify its position in the competitive e-commerce landscape. As an industry leader, Newegg Commerce, Inc. continues to play a significant role in shaping the future of online retail, particularly in the technology and consumer electronics segments. The company's robust business model and innovative approach to e-commerce have positioned it as a key player in the rapidly evolving digital marketplace.

Newegg Commerce, Inc. - Common Shares(NEGG.US) experienced a significant overnight surge of 53.6%, driven by multiple factors. As a leading e-commerce player, Newegg has benefited from the overall growth trend in the tech retail sector, particularly in IT components and consumer electronics. The widespread adoption of remote work and online education has fueled demand for related technology products, boosting Newegg's sales. This substantial price increase likely reflects investor optimism about the company's prospects, possibly stemming from positive financial reports or business updates. However, with a year-to-date change of only 0.8%, the recent rally appears to be a short-term phenomenon. Investors should exercise caution and consider the broader market context when evaluating NEGG's performance and potential for sustained growth.

Septerna, Inc.: Overnight gain 51.0%, Collaboration with Novo Nordisk for metabolic disease treatments boosts investor confidence, driving stock surge.

Septerna, Inc., a clinical-stage biotechnology firm, is at the forefront of developing oral small molecule therapeutics targeting G protein-coupled receptors (GPCRs). Incorporated in Delaware in December 2019 and rebranded in June 2021, the company leverages its proprietary Native Complex Platform™ to unlock the full potential of GPCR-based therapies. The firm's innovative platform technology aims to address unmet medical needs in endocrinology, immunology, inflammation, and metabolic disorders. Septerna's pipeline focuses on advancing novel drug candidates through rigorous clinical development, with the ultimate goal of delivering groundbreaking treatment options to patients in these therapeutic areas. By harnessing the power of its cutting-edge platform, Septerna is poised to revolutionize the approach to GPCR drug discovery and development. The company's strategic focus on oral small molecules could potentially offer significant advantages in terms of patient compliance and accessibility compared to traditional biologic therapies. As Septerna progresses its lead candidates through clinical trials, investors and industry observers are closely monitoring the company's advancements in this highly promising sector of the biotechnology landscape.

Septerna, Inc.(SEPN.US) shares surged 51.0% following the announcement of a landmark collaboration agreement with global pharmaceutical giant Novo Nordisk. The partnership, valued at up to $2.2 billion, aims to develop oral small molecule therapeutics for obesity, type 2 diabetes, and other cardiometabolic diseases. The deal includes over $200 million in upfront and near-term milestone payments, with Novo Nordisk covering all research and development costs. Septerna stands to receive tiered royalties on future product sales. This strategic alliance not only provides Septerna with substantial financial backing but also significantly enhances its position in the biotechnology sector. The collaboration's potential to address major health concerns has sparked strong investor interest, driving the notable stock price increase.

The Top 10 Daily Gainers in the USA market are listed as follows:

Editor's note: This content was generated by Sahm's in-house AI-enabled SaaS tool and was reviewed by our editing team.